Deutsche Bank Ag\ Galectin Therapeutics Inc Transaction History

Deutsche Bank Ag\

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$2.07 - $5.1 $52,611 - $129,621	-25,416 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$1.96 - $2.57 $4,433 - $5,813	-2,262 Reduced 8.17%	25,416 $55,000
Q4 2020 Feb 16, 2021	BUY	$2.24 - $2.87 $16,741 - $21,450	7,474 Added 36.99%	27,678 $62,000
Q3 2020 Nov 12, 2020	BUY	$2.53 - $3.64 $4,543 - $6,537	1,796 Added 9.76%	20,204 $54,000
Q2 2020 Aug 13, 2020	BUY	$1.66 - $3.15 $7,606 - $14,433	4,582 Added 33.14%	18,408 $56,000
Q1 2020 May 14, 2020	SELL	$1.51 - $3.0 $11,270 - $22,392	-7,464 Reduced 35.06%	13,826 $28,000
Q4 2019 Feb 14, 2020	BUY	$2.79 - $4.32 $26,242 - $40,633	9,406 Added 79.15%	21,290 $60,000
Q3 2019 Nov 14, 2019	SELL	$3.0 - $4.05 $54,870 - $74,074	-18,290 Reduced 60.62%	11,884 $42,000
Q2 2019 Aug 14, 2019	SELL	$3.61 - $5.0 $110,393 - $152,900	-30,580 Reduced 50.33%	30,174 $124,000
Q1 2019 May 15, 2019	BUY	$3.86 - $6.02 $234,502 - $365,727	60,752 Added 3037600.0%	60,754 $309,000
Q3 2018 Nov 14, 2018	SELL	$3.68 - $6.93 $4,776 - $8,995	-1,298 Reduced 99.85%	2 $0
Q2 2018 Apr 21, 2020	SELL	$3.16 - $9.16 $6 - $18	-2 Reduced 0.15%	1,300 $8,000
Q2 2018 Aug 14, 2018	SELL	$3.16 - $9.16 $4,101 - $11,889	-1,298 Reduced 49.92%	1,302 $8,000
Q1 2018 Oct 18, 2019	SELL	$3.78 - $5.97 $7 - $11	-2 Reduced 0.08%	2,600 $12,000
Q1 2018 May 15, 2018	BUY	$3.78 - $5.97 $9,828 - $15,522	2,600 Added 130000.0%	2,602 $12,000
Q3 2017 Nov 14, 2017	BUY	$1.67 - $2.3 $3 - $4	2	2 $0

9.65M

1.16M

1.98M

Ticker GALT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,426,000
Market Cap $171M
Description
Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial f...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.